These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16517904)

  • 1. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.
    Sader HS; Fritsche TR; Jones RN
    J Clin Microbiol; 2006 Mar; 44(3):1101-4. PubMed ID: 16517904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2).
    Juretschko S; Labombardi VJ; Lerner SA; Schreckenberger PC;
    J Clin Microbiol; 2007 Apr; 45(4):1339-42. PubMed ID: 17229867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different methods of determining beta-lactam susceptibility in clinical strains of Pseudomonas aeruginosa.
    Torres E; Villanueva R; Bou G
    J Med Microbiol; 2009 May; 58(Pt 5):625-629. PubMed ID: 19369524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different methods for determining beta-lactam susceptibility in Pseudomonas aeruginosa.
    Sapino B; Mazzuccato S; Solinas M; Gion M; Grandesso S
    New Microbiol; 2012 Oct; 35(4):491-4. PubMed ID: 23109018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
    Pottumarthy S; Yu Y; Sader HS; Jones RN; Chen M
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):131-41. PubMed ID: 15939566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.
    Cavallo JD; Hocquet D; Plesiat P; Fabre R; Roussel-Delvallez M;
    J Antimicrob Chemother; 2007 May; 59(5):1021-4. PubMed ID: 17412726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Vitek 2 in antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates with different mechanisms of beta-lactam resistance.
    Mazzariol A; Aldegheri M; Ligozzi M; Lo Cascio G; Koncan R; Fontana R
    J Clin Microbiol; 2008 Jun; 46(6):2095-8. PubMed ID: 18434562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway.
    Kulah C; Aktas E; Comert F; Ozlu N; Akyar I; Ankarali H
    BMC Infect Dis; 2009 Mar; 9():30. PubMed ID: 19291298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria.
    Drissi M; Ahmed ZB; Dehecq B; Bakour R; Plésiat P; Hocquet D
    Med Mal Infect; 2008 Apr; 38(4):187-91. PubMed ID: 18395380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
    Jones RN; Stilwell MG; Rhomberg PR; Sader HS
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):331-4. PubMed ID: 19822273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates.
    Ling TK; Tam PC; Liu ZK; Cheng AF
    J Clin Microbiol; 2001 Aug; 39(8):2964-6. PubMed ID: 11474023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
    Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
    J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study.
    Juan C; Conejo MC; Tormo N; Gimeno C; Pascual Á; Oliver A
    J Antimicrob Chemother; 2013 Mar; 68(3):619-30. PubMed ID: 23143898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Monte Carlo simulation to assess the pharmacodynamics of beta-lactams against Pseudomonas aeruginosa infections in children: a report from the OPTAMA program.
    Ellis JM; Kuti JL; Nicolau DP
    Clin Ther; 2005 Nov; 27(11):1820-30. PubMed ID: 16368453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test.
    Vedel G
    J Antimicrob Chemother; 2005 Oct; 56(4):657-64. PubMed ID: 16144872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime.
    Campo Esquisabel AB; Rodríguez MC; Campo-Sosa AO; Rodríguez C; Martínez-Martínez L
    Clin Microbiol Infect; 2011 Dec; 17(12):1817-22. PubMed ID: 21599797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.